Prescription Pricing for the People Act of 2021
Summary
Prescription Pricing for the People Act of 20 21 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2021
Committee Review
Floor Vote
President
Introduced Apr 27, 2021
Last action Jul 29, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
1
Committee
2
Jul 29, 2021
Upper · Passed
Committee on the Judiciary. Ordered to be reported without amendment favorably.
upper
Apr 27, 2021
Committee
Read twice and referred to the Committee on the Judiciary.
upper
Apr 27, 2021
Introduced
Introduced in Senate
upper
1 primary · 10 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Chuck Grassley
RRepublican
Co
James Lankford
RRepublican
Co
John Boozman
RRepublican
Co
Joni Ernst
RRepublican
Co
Maria Cantwell
DDemocratic
Co
Marsha Blackburn
RRepublican
Co
Mike Braun
RRepublican
Co
Richard Blumenthal
DDemocratic
Co
Shelley Moore Capito
RRepublican
Co
Thom Tillis
RRepublican
Co
Tommy Tuberville
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1388
Scope: US
Hi! I can help you understand S 1388. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline